Finally, we assessed whether the evaluation of NT-proBNP levels in addition to established coronary risk factors could improve risk stratification for MACEs in patients with CCS and pre-DM or DM under secondary prevention therapy in the real world. Here, NPPB is linked to diabetes mellitus.